Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Joseph Shulman

Chief Technical Officer at Rhythm Pharmaceuticals, Inc. (RYTM)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.7M

Reported trades

Filed Stock Type Shares Price Value Since
Aug 17SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 5,07915,915 held (−24%) $119.75 $608K -24.2%
Nov 3SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 9,7488,509 held (−53%) $115.24 $1.1M -21.2%
Oct 30SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 2,8158,509 held (−25%) $115.01 $324K -21.1%
Oct 20SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 2,69320,253 held (−12%) $110.95 $299K -18.2%
Oct 20SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 8,33211,921 held (−41%) $112.06 $934K -19.0%
Oct 20SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 3,4128,509 held (−29%) $112.81 $385K -19.5%
  • Sell

    Chief Technical Officer Joseph Shulman sold $608K of RYTM at $119.75 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Technical Officer Joseph Shulman sold $1.1M of RYTM at $115.24 — cuts the stake by 53%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Technical Officer Joseph Shulman sold $324K of RYTM at $115.01 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Technical Officer Joseph Shulman sold $299K of RYTM at $110.95 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Technical Officer Joseph Shulman sold $934K of RYTM at $112.06 — cuts the stake by 41%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Technical Officer Joseph Shulman sold $385K of RYTM at $112.81 — cuts the stake by 29%; pre-scheduled 10b5-1 plan sale.